Industry

FOOTHILL RANCH, Calif. & COLUMBUS, Ohio–(BUSINESS WIRE)–In a groundbreaking advancement for precision oncology, TAE Life Sciences (TLS) today announced the signing of a Letter of Intent to collaborate with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) in the development and … [Read more…]

CINCINNATI–(BUSINESS WIRE)–Sonida Senior Living has announced the expansion of The Wellington at North Bend Crossing with the addition of its new Vista building, further strengthening its presence in the Cincinnati area. The newly constructed, four-story building is now welcoming visitors for tours ahead of its anticipated summer 2025 opening. The Vista building will add 82 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Medical Imaging Market” report has been added to ResearchAndMarkets.com’s offering. The Medical Imaging Market was valued at USD 63.4 billion in 2024, and is projected to reach USD 82.6 billion by 2029, rising at a CAGR of 5.50%. Report Scope This research report comprehensively analyzes the medical imaging market, including forecasts and sales … [Read more…]

Clinician-focused platform reaches 96% accuracy on the United States Medical Licensing Examination (USMLE), outperforming industry peers on standardized tests MONTREAL–(BUSINESS WIRE)–Pathway today announced that its proprietary large-language model (LLM) scored 96% on a validated set of United States Medical Licensing Examination (USMLE) questions, the highest accuracy yet reported for a specialized medical AI. The result … [Read more…]

Core Revenue of $73.5 million grows 16% year-over-year Reiterating Full Year 2025 Core Revenue Guidance of $310 million Non-GAAP income of $1.2 million, or $0.04 per share; GAAP loss of $11.5 million, or ($0.37) per share Ended Q1 with $814.6 million of cash, cash equivalents, restricted cash, and investments in marketable securities, representing cash per … [Read more…]

  BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that its new generation pan-TRK inhibitor zurletrectinib (ICP-723) has been granted priority review by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA), which accepted the New Drug Application (NDA) … [Read more…]

Partnership combines expert dementia care education with PATHS’ 24/7 digital platform to empower caregivers, equip care teams with real-time insights, and help GUIDE participants meet CMS goals at scale. AUBURN, Ala.–(BUSINESS WIRE)–LifeCare Solutions for Seniors, LLC (LifeCare Solutions), a leader in care management for individuals with complex health needs, today announced a strategic partnership with … [Read more…]

COLUMBUS, Ohio–(BUSINESS WIRE)–PrimaryOne Health and AndHealth celebrated the opening of PrimaryOne Health’s retail and specialty pharmacy on April 29th, 2025. The ribbon cutting marked the expansion of PrimaryOne Health’s pharmacy services where patients can access prescription, specialty, and over-the-counter medications, regardless of insurance coverage or income. PrimaryOne Health’s pharmacy services are powered by a partnership … [Read more…]

The National Pest Management Association shares tips on pest-related health triggers during National Asthma and Allergy Awareness Month FAIRFAX, Va.–(BUSINESS WIRE)–#NationalAsthmaAndAllergyAwarenessMonth–Allergy season is intensifying across the U.S., impacting more than 100 million Americans, and it’s not just pollen causing these symptoms. The National Pest Management Association (NPMA) is joining the Asthma and Allergy Foundation of … [Read more…]

AVB-101 Biomarker Data Readout Expected in 2026 Clinical Milestone Shared at AFTD Annual Caregiver Conference LONDON–(BUSINESS WIRE)–AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced the completion of the second dose cohort in its Phase 1/2 ASPIRE-FTD clinical trial. ASPIRE-FTD is evaluating multiple doses of … [Read more…]